Maxim Ublinskiy1,2, Andrei Manzhurtsev1,2,3, Alexei Yakovlev1,2,3, Natalia Semenova1,2,3, and Tolibjon Akhadov1,3
1Clinical and Research Institute of Emergency Pediatric Surgery and Trauma, Moscow, Russian Federation, 2Insitute of Biochemical Physics, Russian Academy of Sciences, Moscow, Russian Federation, 3Moscow State University, Moscow, Russian Federation
Synopsis
Changes in intensity of BOLD response to
stimulation can serve as a measure of participation of the above processes in
the mechanisms of action of aspirin on vascular system. To test this
hypothesis, we studied the effect of aspirin on the intensity of the BOLD
signal in human brain during visual stimulation.
Introduction
It is known that an increase in neuronal activity in brain areas corresponds to a local increase in the level of oxygenated hemoglobin (Hb), which is provided by blood flow due to vasodilation in neuroactivated areas of excitation. Until now, the most important question about chemical mechanisms that associate a change in activity of neurons with a change in vascular tone remains unresolved.
For the role of substances synthesized in brain cells in response to neuroactivation and causing vasodilation, a number of compounds have been proposed [1,2,3] , among which the main ones are nitric oxide (NO) and derivatives of arachidonic acid (AA). According to Fig. 1 one of the main pathways of vasoldilation (~70% vasodilation effect [1]) is synthesis of prostaglandins (PG) from AA by PGH synthase. The only irreversible inhibitor of PGH synthase is acetylsalicylic acid - aspirin. However, aspirin is not only a PGH synthase inhibitor. It has been shown in rats that aspirin has the property of vasodilation [4] by activating NO formation by acetylation of endothelial NO-synthase [5]. Consequently, aspirin has two opposite effects: inhibiting PGH synthase, that prevents vasodilatation and activating NO synthesis in endothelial cells, that causes vasodilation.
Changes in intensity of BOLD response to stimulation can serve as a measure of participation of the above processes in the mechanisms of action of aspirin on vascular system.
To test this hypothesis, we studied the effect of aspirin on the intensity of the BOLD signal in human brain during visual stimulation.Methods and materials
Study
group consisted of 15 healthy participants in age from 18 to 28 years (mean age
– 24 years). All MRI studies were performed on a Philips Achieva dStream 3.0T
scanner equipped with a 32-channel Philips dStream head
coil. A 5 min fMRI echo
planar imaging (EPI) sequence was acquired (TR=3000 ms, echo time [TE] = 30 ms,
100 dynamics with dynamic scan time = 3 s). A flashing chessboard with a
frequency of 8 Hz will be used as a visual stimuli for fMRI
study (Fig. 2).
All fMRI
studies for each participant were repeated twice: after the first fMRI scan
all participants took a pill of acetylsalicylic acid (aspirin) to inhibit the
prostaglandin synthesis - one of the main ways of vasodilation.
All fMRI were processed using SPM and Anatomy packages (Matlab). A paired t-test was used for intergroup analysis.Results
In all
subjects, the visual cortex was activated statistically significantly
(p < 0.05, FWE). Rest of brain structures do not show a reliable response to neurostimulation.
Intergroup
analysis revealed no change in BOLD signal in visual cortex after aspirin (Fig.3).
However, the effect of aspirin was found in the anterior thalamus, where a
decrease in the intensity of the BOLD response to visual stimulation is
observed with 90% probability (p < 0.09, FWE). The opposite effect (increased
BOLD signal intensity after taking aspirin) was not found in any cerebral
structure.
A
statistically significant (p < 0.05) direct correlation was found between
changes in BOLD signal in thalamus and visual cortex after taking aspirin.
Pearson's correlation coefficient R = 0.79Conclusion
The
observed decrease in hemodynamic response to visual stimulation in thalamus
under the action of aspirin, absence
of the effect of aspirin in the visual cortex and a strong correlation between
changes in BOLD in both structures indicate a different ratio of the activities
of drug-initiated vasodilation and
vasoconstriction processes. Analysis of the distribution of prostaglandin E synthetase in
the human brain showed that the expression of the corresponding gene in
occipital cortex is lower than in the thalamus [6]. The lower content of the
enzyme, the precursor of PGH synthetase, may
be the reason for the lesser effect of its inhibition by aspirin in the cortex
as compared to the thalamus. This creates a statistically significant
vasoconstrictor effect of the drug
in thalamus during video stimulation.Acknowledgements
No acknowledgement found.References
1. D.
Attwell, A. M. Buchan, S. Charpak, M. Lauritzen, B. A. MacVicar, E. A., Nature, 2010, 468, 232; DOI: 10.1038/nature09613.
2. J.
Astrup, D. Heuser, N. A. Lassen, B. Nilsson, K Norberg, B. K. Siesjö, Ciba Found Symp., 1978, 56, 313; DOI: 10.1002/9780470720370.ch16.
3. J.J.
Harris, C. Reynell, D. Attwell., Developmental
cognitive neuroscience, 2011, 1,
199; DOI: 10.1016/j.dcn.2011.04.001.
4. H.
Helgadottir, T.
Tropea, S. Gizurarson, H. Meiri, M. Mandala, Pregnancy Hypertension, 2019, 15,
141; DOI: 10.1016/j.preghy.2019.01.001.
5. D Taubert, R. Berkels, N. Grosser, H.
Schröder, D. Gründemann, E. Schömig, Br.
J. Pharmacol., 2004, 143, 159; DOI:
10.1038/sj.bjp.0705907.
6. P.J.
Jakobsson, S. Thorén, R. Morgenstern, B. Samuelsson, PNAS, 1999, 96, 7220; DOI:
10.1073/pnas.96.13.7220.